WVE

Wave Life Sciences (WVE)

About Wave Life Sciences (WVE)

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It develops and commercializes a pipeline of RNA medicines across a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Details

Daily high

$6.30

Daily low

$6.09

Price at open

52 Week High

$21.73

52 Week Low

$5.02

Market cap

1.2B

Dividend yield

0.00%

Volume

2,082

Avg. volume

3.3M

P/E ratio

-5.85

Wave Life Sciences News